Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
Top Sells
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
$1.51B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
$436M |
| 3 |
Citigroup
C
|
$305M |
| 4 |
American Express
AXP
|
$198M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
$123M |
Sector Composition
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
451
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.69M | ﹤0.01% |
393,266
-7,249
| -2% | -$49.7K |
|
452
Quanex
NX
$836M
| $2.65M | ﹤0.01% |
152,132
+1,999
| +1% | +$34.8K |
|
453
Nike
NKE
$109B
| $2.63M | ﹤0.01% |
39,559
-139
| -0.4% | -$9.23K |
|
454
iShares Global Healthcare ETF
IXJ
$3.85B
| $2.59M | ﹤0.01% |
46,444
-681,418
| -94% | -$37.9M |
|
|
ARRY
455
DELISTED
Array Biopharma Inc
ARRY
| $2.58M | ﹤0.01% |
158,223
-3,210
| -2% | -$52.4K |
|
|
CLVS
456
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | ﹤0.01% |
47,961
| – | – |
|
|
CSFL
457
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $2.47M | ﹤0.01% |
93,257
+1,399
| +2% | +$37.1K |
|
458
Icon
ICLR
$13.6B
| $2.47M | ﹤0.01% |
20,916
-4,200
| -17% | -$496K |
|
|
ICPT
459
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.45M | ﹤0.01% |
39,752
-100
| -0.3% | -$6.15K |
|
|
LMNX
460
DELISTED
Luminex Corp
LMNX
| $2.36M | ﹤0.01% |
111,939
+246
| +0.2% | +$5.18K |
|
|
PRAH
461
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.35M | ﹤0.01% |
28,380
-5,170
| -15% | -$429K |
|
462
PNC Financial Services
PNC
$80.5B
| $2.33M | ﹤0.01% |
15,382
-7,618
| -33% | -$1.15M |
|
463
Southside Bancshares
SBSI
$932M
| $2.28M | ﹤0.01% |
65,707
-691
| -1% | -$24K |
|
|
PGNX
464
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.27M | ﹤0.01% |
303,692
| – | – |
|
465
CF Industries
CF
$13.7B
| $2.25M | ﹤0.01% |
59,727
-2,429
| -4% | -$91.6K |
|
466
Knowles
KN
$1.85B
| $2.24M | ﹤0.01% |
177,698
-12,025
| -6% | -$151K |
|
|
MNTA
467
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.21M | ﹤0.01% |
121,507
-3,000
| -2% | -$54.4K |
|
468
Booking.com
BKNG
$178B
| $2.15M | ﹤0.01% |
1,034
-64
| -6% | -$133K |
|
469
Petrobras Class A
PBR.A
$72.8B
| $2.13M | ﹤0.01% |
164,202
| – | – |
|
470
SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.33B
| $2.04M | ﹤0.01% |
79,676
-2,028
| -2% | -$52K |
|
471
Travere Therapeutics
TVTX
$1.93B
| $1.97M | ﹤0.01% |
87,905
| – | – |
|
472
VanEck Vietnam ETF
VNM
$586M
| $1.96M | ﹤0.01% |
100,100
| – | – |
|
473
Lantheus
LNTH
$3.72B
| $1.91M | ﹤0.01% |
119,793
+1,820
| +2% | +$28.9K |
|
474
B&G Foods
BGS
$374M
| $1.88M | ﹤0.01% |
79,119
+1,465
| +2% | +$34.7K |
|
475
Entravision Communication
EVC
$226M
| $1.86M | ﹤0.01% |
394,803
+7,551
| +2% | +$35.5K |
|